Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Dzhangar Dzhumashev"'
Autor:
Andrea Timpanaro, Caroline Piccand, Dzhangar Dzhumashev, Stenija Anton-Joseph, Andrea Robbi, Janine Moser, Jochen Rössler, Michele Bernasconi
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 42, Iss 1, Pp 1-30 (2023)
Abstract Background Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in childhood, whose prognosis is still poor especially for metastatic, high-grade, and relapsed RMS. New treatments are urgently needed, especially systemic therapies.
Externí odkaz:
https://doaj.org/article/eba3d6375e904fe5b2a50514e336fecc
Autor:
Zelia L Gouveia, Sandrine Moutel, Beat W. Schäfer, Franck Perez, Gianmarco Meier, Nagjie Alijaj, Michele Bernasconi, Maurizio Roveri, Paola Luciani, Jochen Rössler, Maxim Gray, Florian Weber, Dzhangar Dzhumashev
Publikováno v:
Cancers, Vol 12, Iss 3313, p 3313 (2020)
Cancers
Alijaj, Nagjie; Moutel, Sandrine; Gouveia, Zelia L; Gray, Maxim; Roveri, Maurizio; Dzhumashev, Dzhangar; Weber, Florian; Meier, Gianmarco; Luciani, Paola; Rössler, Jochen K.; Schäfer, Beat W; Perez, Franck; Bernasconi, Michele (2020). Novel FGFR4-Targeting Single-Domain Antibodies for Multiple Targeted Therapies against Rhabdomyosarcoma. Cancers, 12(11) MDPI AG 10.3390/cancers12113313
Volume 12
Issue 11
Cancers
Alijaj, Nagjie; Moutel, Sandrine; Gouveia, Zelia L; Gray, Maxim; Roveri, Maurizio; Dzhumashev, Dzhangar; Weber, Florian; Meier, Gianmarco; Luciani, Paola; Rössler, Jochen K.; Schäfer, Beat W; Perez, Franck; Bernasconi, Michele (2020). Novel FGFR4-Targeting Single-Domain Antibodies for Multiple Targeted Therapies against Rhabdomyosarcoma. Cancers, 12(11) MDPI AG 10.3390/cancers12113313
Volume 12
Issue 11
Simple Summary Rhabdomyosarcoma (RMS) accounts for more than 50% of all soft tissue sarcomas in childhood and adolescence. Despite progress and intensified multimodality treatment, prognoses are extremely poor with an overall survival rate of approxi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61055120eb9ff928685d4b74c17cd6a1
https://www.mdpi.com/2072-6694/12/11/3313
https://www.mdpi.com/2072-6694/12/11/3313
Autor:
Dzhangar Dzhumashev, Tatiana Levada, Elmira Safarovа, Evgeny Metelkin, Kevin McDonnell, Stephen E. Zale, Alexandra Urusova, Greg Troiano, Vladimir Shalgunov, Dmitry Andreyev, Arkadi Zintchenko, Yuri Shilov, Daria Zaytseva-Zotova, Oleg Demin
Publikováno v:
Journal of controlled release : official journal of the Controlled Release Society. 261
Nanoparticles made of polylactide-poly(ethylene glycol) block-copolymer (PLA-PEG) are promising vehicles for drug delivery due to their biodegradability and controllable payload release. However, published data on the drug delivery properties of PLA-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac1a677141f82b0b74ba69e5f9535542
https://pubmed.ncbi.nlm.nih.gov/28611009
https://pubmed.ncbi.nlm.nih.gov/28611009